{
  "id": "831f642fd5090f72",
  "title": "Moleculin Biotech Highlights Phase 3 Annamycin AML Catalysts , Eyes Partnering Within 12 Months",
  "description": "20260215T153000Z",
  "content": "",
  "source": "themarketsdaily.com",
  "source_url": "https://www.themarketsdaily.com/2026/02/15/moleculin-biotech-highlights-phase-3-annamycin-aml-catalysts-eyes-partnering-within-12-months.html",
  "published_at": "20260215T153000Z",
  "fetched_at": "2026-02-16T00:29:41.976443+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.themarketsdaily.com/2026/02/15/moleculin-biotech-highlights-phase-3-annamycin-aml-catalysts-eyes-partnering-within-12-months.html",
    "url_mobile": "",
    "title": "Moleculin Biotech Highlights Phase 3 Annamycin AML Catalysts , Eyes Partnering Within 12 Months",
    "seendate": "20260215T153000Z",
    "socialimage": "",
    "domain": "themarketsdaily.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}